mepivacaine has been researched along with Atrophy in 1 studies
Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otake, T | 1 |
| Ieshima, H | 1 |
| Ishida, H | 1 |
| Ushigome, Y | 1 |
| Saito, S | 1 |
1 trial available for mepivacaine and Atrophy
| Article | Year |
|---|---|
Bone atrophy in complex regional pain syndrome patients measured by microdensitometry.
Topics: Administration, Oral; Analysis of Variance; Anesthetics, Local; Atrophy; Autonomic Nerve Block; Bone | 1998 |